Konstantinos Xanthopoulos

816 total citations
37 papers, 376 citations indexed

About

Konstantinos Xanthopoulos is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Konstantinos Xanthopoulos has authored 37 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 7 papers in Neurology and 6 papers in Physiology. Recurrent topics in Konstantinos Xanthopoulos's work include Prion Diseases and Protein Misfolding (13 papers), Neurological diseases and metabolism (6 papers) and RNA Research and Splicing (6 papers). Konstantinos Xanthopoulos is often cited by papers focused on Prion Diseases and Protein Misfolding (13 papers), Neurological diseases and metabolism (6 papers) and RNA Research and Splicing (6 papers). Konstantinos Xanthopoulos collaborates with scholars based in Greece, Germany and United States. Konstantinos Xanthopoulos's co-authors include Theodoros Sklaviadis, Dimitra Dafou, Ειrini Kanata, Alexandros Garyfallos, Anastasios I. Stamou, Georgios Theodoridis, Tamar Canello, Matthias Schmitz, Inga Zerr and Marı́a Gasset and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Konstantinos Xanthopoulos

31 papers receiving 370 citations

Peers

Countries citing papers authored by Konstantinos Xanthopoulos

Since Specialization

Citations

This map shows the geographic impact of Konstantinos Xanthopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstantinos Xanthopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstantinos Xanthopoulos more than expected).

Fields of papers citing papers by Konstantinos Xanthopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konstantinos Xanthopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstantinos Xanthopoulos. The network helps show where Konstantinos Xanthopoulos may publish in the future.

Co-authorship network of co-authors of Konstantinos Xanthopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Konstantinos Xanthopoulos. A scholar is included among the top collaborators of Konstantinos Xanthopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konstantinos Xanthopoulos. Konstantinos Xanthopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecularly designed deep eutectic solvents based on choline for site-specific delivery of luteolin in the oral cavity 2025 ·International Journal of Pharmaceutics ·(unknown), Afroditi Kapourani, (unknown), (unknown), (unknown), Dimitra Dafou, Joseph Kioseoglou, Konstantinos Xanthopoulos, Dimitrios G. Fatouros, Panagiotis Barmpalexis	0
2	Enhancing luteolin solubility through solid dispersion-based oral gels: A novel approach for periodontal disease treatment 2025 ·Journal of Drug Delivery Science and Technology ·(unknown), Afroditi Kapourani, (unknown), (unknown), (unknown), Dimitra Dafou, Theodoros Sklaviadis, (unknown), Spyros Papageorgiou, Andreana N. Assimopoulou, Konstantinos Xanthopoulos, Dimitrios G. Fatouros, Panagiotis Barmpalexis	1
3	Titanium Dioxide Solar Photocatalytic Microbial Inactivation Assessment Utilizing Viability Tests and a Novel Triplex qPCR Assay for Nucleic Acid Degradation Determination 2025 ·Molecules ·Ioannis Paspaltsis, Ειrini Kanata, (unknown), Chrysanthi Berberidou, (unknown), (unknown), Konstantinos Xanthopoulos, Dimitra Dafou, Ioannis Poulios, Theodoros Sklaviadis	0
4	A Comparison of RML Prion Inactivation Efficiency by Heterogeneous and Homogeneous Photocatalysis 2024 ·Pathogens ·Ioannis Paspaltsis, Ειrini Kanata, (unknown), (unknown), Matthias Schmitz, Inga Zerr, Dimitra Dafou, Konstantinos Xanthopoulos, Theodoros Sklaviadis	1
5	SIMOA Diagnostics on Alzheimer’s Disease and Frontotemporal Dementia 2024 ·Biomedicines ·(unknown), (unknown), Ειrini Kanata, Kostas Vekrellis, Vasilios C. Constantinides, George P. Paraskevas, (unknown), Matthias Schmitz, Inga Zerr, Konstantinos Xanthopoulos, Theodoros Sklaviadis, Dimitra Dafou	5
6	Αnti-prion effects of anthocyanins 2024 ·Redox Biology ·(unknown), (unknown), Ειrini Kanata, (unknown), (unknown), (unknown), Susana Correia, Matthias Schmitz, Inga Zerr, Ioannis Tsamesidis, Konstantinos Xanthopoulos, Dimitra Dafou, Theodoros Sklaviadis	0
7	RNA editing regulates glutamatergic synapses in the frontal cortex of a molecular subtype of Amyotrophic Lateral Sclerosis 2024 ·Molecular Medicine ·(unknown), Dimitra Dafou, Konstantinos Xanthopoulos, Theodoros Sklaviadis, Ειrini Kanata	3
8	Limited preventive effects of empagliflozin against metabolic dysfunction-associated steatotic liver disease in a mouse model of fast food diet 2024 ·HORMONES ·Evangelia Makri, Konstantinos Xanthopoulos, (unknown), Antonis Goulas, (unknown), (unknown), Anastasia Tsingotjidou, Angeliki Cheva, (unknown), Constantinos K. Zacharis, (unknown), Spyridon Gerou, Stergios A. Pοlyzos	0
9	Synthesis, structural characterization and study of antioxidant and anti-PrPSc properties of flavonoids and their rhenium(I)–tricarbonyl complexes 2023 ·JBIC Journal of Biological Inorganic Chemistry ·(unknown), (unknown), Konstantinos Xanthopoulos, (unknown), Susana Correia, (unknown), Katrin Thüne, Antonios G. Hatzidimitriou, Inga Zerr, Matthias Schmitz, Theodoros Sklaviadis, Dimitra Hadjipavlou‐Litina, Dionysia Papagiannopoulou	3
10	Pilot‐scale photocatalytic detoxification and disinfection of hazardous medical wastewater 2023 ·Journal of Chemical Technology & Biotechnology ·Chrysanthi Berberidou, (unknown), Ioannis Paspaltsis, Vasiliki Kitsiou, Ειrini Kanata, Konstantinos Xanthopoulos, Theodoros Sklaviadis, (unknown), Ioannis Poulios	2
11	Gene targeting in amyotrophic lateral sclerosis using causality-based feature selection and machine learning 2023 ·Molecular Medicine ·(unknown), Dimitra Dafou, Ειrini Kanata, Theodoros Sklaviadis, Theodoros P. Zanos, Anastasios Gounaris, Konstantinos Xanthopoulos	14
12	RNA Editing Alterations Define Disease Manifestations in the Progression of Experimental Autoimmune Encephalomyelitis (EAE) 2022 ·Cells ·Dimitra Dafou, Ειrini Kanata, (unknown), (unknown), Athanasios Dimitriadis, (unknown), Roza Lagoudaki, Paschalis Theotokis, Olga Touloumi, (unknown), Evangelia Kesidou, Konstantinos Xanthopoulos, Nikolaos Grigoriadis, F. Nina Papavasiliou, Theodoros Sklaviadis	6
13	Profiling Microglia through Single-Cell RNA Sequencing over the Course of Development, Aging, and Disease 2022 ·Cells ·(unknown), (unknown), Ειrini Kanata, (unknown), (unknown), Konstantinos Xanthopoulos, Theodoros Sklaviadis, Dimitra Dafou	25
14	Carnosic Acid and Carnosol Display Antioxidant and Anti-Prion Properties in In Vitro and Cell-Free Models of Prion Diseases 2022 ·Antioxidants ·(unknown), (unknown), Ειrini Kanata, (unknown), Katrin Thüne, Matthias Schmitz, Ioannis Tsamesidis, Evgenia Lymperaki, Konstantinos Xanthopoulos, Theodoros Sklaviadis, Dimitra Dafou	21
15	A Systematic Review of Common and Brain-Disease-Specific RNA Editing Alterations Providing Novel Insights into Neurological and Neurodegenerative Disease Manifestations 2022 ·Biomolecules ·(unknown), (unknown), (unknown), Ειrini Kanata, (unknown), Konstantinos Xanthopoulos, Dimitra Dafou, Theodoros Sklaviadis	15
16	MicroRNA Alterations in the Brain and Body Fluids of Humans and Animal Prion Disease Models: Current Status and Perspectives 2018 ·Frontiers in Aging Neuroscience ·Ειrini Kanata, Katrin Thüne, Konstantinos Xanthopoulos, Isidró Ferrer, Dimitra Dafou, Inga Zerr, Theodoros Sklaviadis, Franc Llorens	17
17	Down-regulation of the Tumor Suppressor CYLD Enhances the Transformed Phenotype of Human Breast Cancer Cells 2017 ·Anticancer Research ·Timoklia Orfanidou, Konstantinos Xanthopoulos, Dimitra Dafou, (unknown), (unknown), (unknown), Eudoxia Hatzivassiliou, George Mosialos	14
18	Immunization with Recombinant Prion Protein Leads to Partial Protection in a Murine Model of TSEs through a Novel Mechanism 2013 ·PLoS ONE ·Konstantinos Xanthopoulos, (unknown), (unknown), Christos A. Kyratsous, Christos Α. Panagiotidis, Nikolaos Grigoriadis, Minas Yiangou, Theodoros Sklaviadis	17
19	Inhibition of PrP^Scformation in scrapie infected N2a cells by 5,7,8-trimethyl-3,4-dihydro-2H-1,4-benzoxazine derivatives 2012 ·Prion ·Fani Koukouli, Ioannis Paspaltsis, Evgenia Salta, Konstantinos Xanthopoulos, (unknown), Theodora Calogeropoulou, Theodoros Sklaviadis	6
20	Species and Strain Glycosylation Patterns of PrPSc 2009 ·PLoS ONE ·Konstantinos Xanthopoulos, Magdalini Polymenidou, S. J. Bellworthy, Sylvie L. Benestad, Theodoros Sklaviadis	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact